| |
|
FDA approves new innovative cochlear implant system
|
| |
Denver, USA (PRNewswire-FirstCall): Cochlear Americas announced today that it recently received approval from the U.S. Food and Drug Administration (FDA) to market the Nucleus(R) Freedom(TM) cochlear implant system. The Nucleus Freedom, which features both an internal component and an external speech processor, will begin shipping to clinics on April 3, 2005. The Nucleus Freedom is designed to mimic functions of the human ear and fit seamlessly into a user's lifestyle.
For more information, please visit:
www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/03-14-2005/0003194080&EDATE
|
|